Viewing Study NCT00741403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-06-02 @ 7:50 AM
Study NCT ID: NCT00741403
Status: COMPLETED
Last Update Posted: 2016-12-29
First Post: 2008-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies
Sponsor: Cornerstone Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Metastatic Cancer View
None Lymphoma View
None Solid Tumors View
None Advanced Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None malignancies View
None refractory View
None relapsed View